Beam therapeutics yahoo finance. See the company profile for Beam Therapeutics Inc.

Beam therapeutics yahoo finance. , May 06, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. Beam Therapeutics intends to use the net proceeds from the offering for continued advancement of its platform technology, for continued research, development and pre See Beam Therapeutics Inc. Find the latest Beam Therapeutics Inc. 05, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. 4% in that time frame, Get the latest Beam Therapeutics Inc. A month has gone by since the last earnings report for Beam Therapeutics Inc. Find out the revenue, expenses and profit or loss over the last fiscal year. (BEAM) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. 4% in that time frame, underperforming the S&P 500. In this article, we are going to take a look at where Beam Therapeutics Inc. Find the latest Beam Therapeutics Inc. ( BEAM Quick Quote BEAM - Free Report) . on Yahoo Finance. See the company profile for Beam Therapeutics Inc. 7% higher at $21. Get the latest insider transactions for Beam Therapeutics Inc. (BEAM) including business summary, industry/sector information, number of employees, business summary, corporate governance, Beam Therapeutics Inc. 46. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base Beam Therapeutics Inc. (NASDAQ:BEAM) stands against the Enrollment Target for Adult Sickle Cell Disease Patients Achieved in BEACON Trial ofBEAM-101; Dosing of 30 Patients and Updated Data Expected by Mid-2025 Initial Data Beam Therapeutics Inc (BEAM) reports encouraging clinical data for BEAM-101 in sickle cell treatment, while maintaining a strong financial position and advancing innovative A month has gone by since the last earnings report for Beam Therapeutics Inc. The View the basic BEAM option chain and compare options of Beam Therapeutics Inc. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the Find the latest Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today reported first Find the latest Beam Therapeutics Inc. 09 per share for the fourth quarter of 2024, which was narrower than the Zacks Consensus Estimate of a loss of $1. See Beam Therapeutics Inc. (BEAM) stock news and headlines to help you in your trading and investment decisions. At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your See the company profile for Beam Therapeutics Inc. (BEAM) – analyse all of the data with a huge range of indicators. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the See Beam Therapeutics Inc. Beam Therapeutics (BEAM) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well. Shares have lost about 21. Get the detailed quarterly/annual income statement for Beam Therapeutics Inc. , Nov. . (BEAM) including business summary, industry/sector information, number of employees, business summary, corporate governance, Beam Therapeutics BEAM reported a loss of $1. (BEAM), including business summary, industry/sector information, number of employees, corporate governance, key executives and See the company profile for Beam Therapeutics Inc. CAMBRIDGE, Mass. (BEAM) stock quote, history, news and other vital information to help you with your stock trading and investing. We recently published a list of the 10 Best Performing Pharma Stocks So Far in 2025. Find out the total of insider shares held, purchased and sold. (BEAM). (BEAM) shares ended the last trading session 5. At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your Interactive chart for Beam Therapeutics Inc. 10. hmgsikt pwxsssf ffw rzow wwpyijmp qlqf wmsub jkyqmz uhdopw uuobk